World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
34132
World Ranking
15897
National Ranking
8000

Overview

Satish K. Garg is affiliated with the University of Colorado Anschutz Medical Campus in the United States. Their research primarily focuses on various aspects of diabetes, encompassing clinical management, technological advancements, and metabolic studies.

The scientist's recent publications reflect contributions to diabetes research and technology, including the following papers:

  • Continuous glucose monitoring and metrics for clinical trials: an international consensus statement (2022, The Lancet Diabetes & Endocrinology)
  • Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice (2022, Endocrine Reviews)
  • Safety and Glycemic Outcomes During the MiniMed™ Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes (2021, Diabetes Technology & Therapeutics)
  • Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities (2020, Diabetes Technology & Therapeutics)
  • The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction (2020, Diabetes Technology & Therapeutics)

The body of work involves collaboration with several frequent co-authors, including:

  • Irl B. Hirsch
  • Bruce W. Bode
  • Mark P. Christiansen
  • Robert A. Vigersky
  • Halis Kaan Aktürk

Among the main fields of study connected to their research is Medicine, with a strong emphasis on subfields such as:

  • Endocrinology, Diabetes and Metabolism
  • Surgery
  • Genetics
  • Epidemiology
  • Physiology

The scientist's publications are frequently found in the following venues:

  • Diabetes Technology & Therapeutics
  • Diabetes
  • UNC Libraries
  • Scientific Reports
  • Diabetes Care

The research topics explored in their work include:

  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Diabetes Treatment and Management
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Metabolism, Diabetes, and Cancer
  • Heavy Metal Exposure and Toxicity

Best Publications

  • Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    Tadej Battelino;Thomas Danne;Richard M. Bergenstal;Stephanie A. Amiel

  • International Consensus on Use of Continuous Glucose Monitoring

    Thomas Danne;Revital Nimri;Tadej Battelino;Richard M. Bergenstal

  • State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

    Nicole C Foster;Roy W Beck;Kellee M Miller;Mark A Clements

  • Threshold-based insulin-pump interruption for reduction of hypoglycemia

    Richard M. Bergenstal;David C. K Klonoff;Satish K. Garg;Bruce W. Bode

  • Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial.

    Satish Garg;Howard Zisser;Sherwyn Schwartz;Timothy Bailey

  • Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes

    Richard M. Bergenstal;Satish Garg;Stuart A. Weinzimer;Bruce A. Buckingham

  • Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.

    Robert E. Ratner;Irl B. Hirsch;James L. Neifing;Satish K. Garg

  • Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

    Satish K Garg;Stuart A Weinzimer;William V Tamborlane;Bruce A Buckingham

  • Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

    Simon Heller;John Buse;Miles Fisher;Satish Garg

  • Clinical evaluation of the GlucoWatch biographer: a continual, non-invasive glucose monitor for patients with diabetes.

    M J Tierney;J A Tamada;R O Potts;L Jovanovic

  • Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP).

    Richard M. Bergenstal;Andrew J. Ahmann;Timothy Bailey;Roy W. Beck

  • Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes.

    H P Chase;S K Garg;G Marshall;C L Berg

  • Noninvasive Glucose Monitoring: Comprehensive Clinical Results

    Janet A. Tamada;Satish Garg;Lois Jovanovic;Kenneth R. Pitzer

  • Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults With Type 1 Diabetes

    Satish K. Garg;Sherwyn Schwartz;Steven V. Edelman

  • Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes

    Satish K. Garg;Robert R. Henry;Phillip Banks;John B. Buse

  • Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes.

    S K Garg;R O Potts;N R Ackerman;S J Fermi

  • Effect of Type 1 Diabetes on the Gender Difference in Coronary Artery Calcification: a Role for Insulin Resistance?: The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study

    Dana Dabelea;Gregory Kinney;Janet K. Snell-Bergeon;John E. Hokanson

  • Diabetes and cancer: two diseases with obesity as a common risk factor

    S. K. Garg;H. Maurer;K. Reed;R. Selagamsetty;R. Selagamsetty

  • Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

    Paresh Dandona;Chantal Mathieu;Moshe Phillip;Lars Hansen

  • International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors

    Thomas Danne;Satish Garg;Anne L. Peters;John B. Buse

Frequent Co-Authors

Alicia J. Jenkins
Alicia J. Jenkins University of Sydney
Marian Rewers
Marian Rewers University of Colorado Denver
Irl B. Hirsch
Irl B. Hirsch University of Washington
John B. Buse
John B. Buse University of North Carolina at Chapel Hill
Anne L. Peters
Anne L. Peters University of Southern California
Christopher E. Aston
Christopher E. Aston University of Oklahoma Health Sciences Center
William V. Tamborlane
William V. Tamborlane Yale University
David M. Maahs
David M. Maahs Stanford University
Bruce A. Buckingham
Bruce A. Buckingham Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives and pathways related to studying medicine in the USA can open numerous opportunities in healthcare. Many students consider becoming a registered nurse, and there are now more options than ever for flexible learning. Those looking to save on tuition and study online may want to review the cheapest bsn programs that offer quality education without a high cost.

For individuals wishing to accelerate their entry into advanced nursing roles, there are direct msn programs online designed for non-nursing graduates, allowing career changers to quickly transition into the nursing profession.

Some students may be seeking a smoother admission process. If so, it’s helpful to learn about the easiest nursing schools to get into, which offer streamlined requirements and more accessible entry points.

Another excellent allied health option is medical billing and coding. Many programs can be completed online and offer financial support. You can find programs at medical billing and coding online schools that accept financial aid.

Best Scientists Citing Satish K. Garg

Trending Scientists

Recently Published Articles